AcouSort’s collaboration with the global life science company has reached yet another significant milestone with the signing of a Statement of Work (SoW) describing Phase 3 in the ongoing collaboration. The new assignment will generate revenues of at least
The collaboration, which began in 2022, aims to demonstrate how AcouSort’s AcouWash technology can be adapted for industrial use and integrated as OEM components to automate certain processing steps in the partnering company’s future cell therapy products and instruments. The feedback from the partnering company has been positive throughout the collaboration and in the now agreed phase 3,
“With the positive feedback we have received throughout the collaboration, the signing of the SoW comes as no surprise, but is still extremely gratifying.
© Modular Finance, source